Corporate Archives - Triple Hair

Triple Hair Wins “Jury’s Choice Award” at Octane Aesthetic Tech Forum

Posted on February 12, 2024 (February 12, 2024) by Pascale Bouchard

[…]

Triple Hair Group Signs Licensing Agreement for South Korean Market with Mother’s Pharmaceutical

Posted on October 17, 2023 (February 15, 2024) by Pascale Bouchard

[…]

OpportunitiesNB Article on an interview with our CEO Jean-Phillipe Gravel

Posted on July 27, 2023 by Pascale Bouchard

[…]

Triple Hair Group receives Health Canada approval to start Phase III clinical trials on its Therapy-07 prescription drug in Canada

Posted on June 28, 2023 by Pascale Bouchard

[…]

Triple Hair Group consolidates its position as industry leader and innovator for its Therapy-07 prescription drug in the U.S.

Posted on June 19, 2023 by Pascale Bouchard

[…]

Triple Hair Group Reports Positive Results from Safety Studies on its Therapy-07 Prescription Drug

Posted on June 14, 2023 by Pascale Bouchard

[…]

New Possibilities in Hair Loss Prescription Therapies

Posted on August 11, 2022 (August 11, 2022) by Julie-Anne Rioux

[…]

Triple Hair Group announces strategic arrangement with leading US compounding company Pharmacy Solutions

Posted on June 21, 2022 (June 28, 2022) by Jean-Philippe Gravel

Triple Hair Group Inc. (“Triple Hair” or the “Company”), a company specializing in the development of innovative treatments for alopecia, is pleased to announce that it has entered into a strategic licensing agreement with Pharmacy Solutions to compound Triple Hair’s hair growth products in the United States. Alopecia is an under-served global market of USD 7.8 billion in 2021, estimated to reach USD 14.2 billion in 2028. […]